Correlation Between MediciNova and Immutep

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MediciNova and Immutep at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MediciNova and Immutep into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MediciNova and Immutep Ltd ADR, you can compare the effects of market volatilities on MediciNova and Immutep and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MediciNova with a short position of Immutep. Check out your portfolio center. Please also check ongoing floating volatility patterns of MediciNova and Immutep.

Diversification Opportunities for MediciNova and Immutep

0.26
  Correlation Coefficient

Modest diversification

The 3 months correlation between MediciNova and Immutep is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding MediciNova and Immutep Ltd ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immutep Ltd ADR and MediciNova is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MediciNova are associated (or correlated) with Immutep. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immutep Ltd ADR has no effect on the direction of MediciNova i.e., MediciNova and Immutep go up and down completely randomly.

Pair Corralation between MediciNova and Immutep

Given the investment horizon of 90 days MediciNova is expected to generate 0.94 times more return on investment than Immutep. However, MediciNova is 1.07 times less risky than Immutep. It trades about 0.19 of its potential returns per unit of risk. Immutep Ltd ADR is currently generating about 0.06 per unit of risk. If you would invest  183.00  in MediciNova on September 15, 2024 and sell it today you would earn a total of  31.00  from holding MediciNova or generate 16.94% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

MediciNova  vs.  Immutep Ltd ADR

 Performance 
       Timeline  
MediciNova 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in MediciNova are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, MediciNova showed solid returns over the last few months and may actually be approaching a breakup point.
Immutep Ltd ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Immutep Ltd ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable primary indicators, Immutep is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

MediciNova and Immutep Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MediciNova and Immutep

The main advantage of trading using opposite MediciNova and Immutep positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MediciNova position performs unexpectedly, Immutep can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immutep will offset losses from the drop in Immutep's long position.
The idea behind MediciNova and Immutep Ltd ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.